An interdisciplinary research team has successfully developed an innovative inhibitor that shows promise in fighting obesity and potentially preventing heart disease. The team developed an anti-obesity drug that blocks the effects of cytochrome P450 8B1, the enzyme linked to cholesterol absorption and obesity.